Lamazym Aftercare Study

Clinical trial NCT01908725 · COMPLETED

Trial details

NCT number: NCT01908725
Sponsor: Chiesi Farmaceutici S.p.A.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alpha-Mannosidosis

Start date: 2013-06-01
Primary completion: 2022-09-30
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.